Diadema Partners »

Pharvaris N V shares owned by Diadema Partners

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $828k 29k 28.25

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Pharvaris N V

General Atlantic
FMR
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Deerfield Management Company
Bain Capital Life Sciences Investors
Wellington Management Company
Commodore Capital
Novo A/S
Saturn V Capital Management
Point72 Asset Management
Cormorant Asset Management
Sofinnova Ventures

View all funds holding Pharvaris N V